Company profile: Excision Medical
1.1 - Company Overview
Company description
- Provider of tools for TAVR procedures focused on safe, reliable leaflet modification and excision, device steering, and temporary hemodynamic support. Offerings include the Leaflet Excision System to target and excise aortic valve leaflets and mitigate risks during redo TAVR, StΓ½ri steering catheters, Viking RF Excision Catheter, and HemoShield temporary valve.
Products and services
- Leaflet Excision System: Custom-engineered device enabling physicians to precisely target and excise one or more aortic valve leaflets, addressing hemodynamic needs and mitigating risks during redo TAVR procedures
- Viking (RF Excision Catheter): RF-enabled catheter employing radiofrequency energy to excise aortic valve leaflets with focused energy delivery, supporting leaflet modification central to Excision Medicalβs TAVR focus
- HemoShield (Temporary Valve): Clinical-grade temporary valve used during TAVR procedures to maintain hemodynamic stability for patients undergoing valve leaflet modification
Key contacts
π
π
Financial details
π
1.2 - Competitors and similar companies to Excision Medical
Acesion Pharma
HQ: Denmark
Website
- Description: Provider of medical drugs for the treatment of atrial fibrillation, developing therapies that inhibit a heart cell ion channel. Offerings include AP30663, an intravenous drug for acute cardioversion to sinus rhythm with demonstrated efficacy in clinical trials, and AP31969, an oral drug for maintenance of sinus rhythm in patients with atrial fibrillation, currently in clinical development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Acesion Pharma company profile β
Soley Therapeutics
HQ: United States
Website
- Description: Provider of AI-driven drug discovery solutions combining molecular and cellular response detection, including a proprietary platform that decodes cellular responses to predict cell fate, cellular sensing and anticipatory biology methods, and stress-modulating/tumor-targeting therapeutic discovery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Soley Therapeutics company profile β
Cardialen
HQ: United States
Website
- Description: Provider of pain-free cardioversion therapies for atrial fibrillation, developing implantable low-energy (low voltage) atrial cardioverters to address major unmet needs of this condition.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Cardialen company profile β
VIA Pharmaceuticals
HQ: United States
Website
- Description: Provider of biotechnology solutions focused on developing small-molecule drugs to treat cardiovascular diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full VIA Pharmaceuticals company profile β
TandemLife
HQ: United States
Website
- Description: Provider of innovative medical device products for cardiologists and cardiac surgeons worldwide, delivering unique solutions for patients requiring circulatory support, including the FDA-cleared TandemHeart System that provides extracorporeal circulatory support in minutes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full TandemLife company profile β
π
2.M&A buyers
2.1 Potential strategic acquirers in the sector
π
π
π
π
View all strategic buyers with complete profiles
Start Free Trial β
2.2 - Strategic buyer groups for Excision Medical
π
Buyer group 1: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 2: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 3: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial β
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Excision Medical
2.2 - Growth funds investing in similar companies to Excision Medical
π
View all growth equity funds with complete profiles
Start Free Trial β
4 - Top valuation comps for Excision Medical
4.2 - Public trading comparable groups for Excision Medical
π Unlock all public trading comparable groups with complete valuation data
Start Free Trial β